...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: Selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels
【24h】

Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: Selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels

机译:人肌肉导管中血管张力和脉搏波速度的调节:一氧化氮供体相对于阻力血管扩张肌肉动脉的选择性作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Arterial tone in muscular conduit arteries may influence pressure wave reflection through changes in diameter and pulse wave velocity. We examined the relative specificity of vasodilator drugs for radial artery and forearm resistance vessels during intrabrachial arterial infusion. The nitric oxide (NO) donors, nitroglycerine and nitroprusside, and brain natriuretic peptide were compared with the α-adrenergic antagonist phentolamine, calcium-channel antagonist verapamil, and hydralazine. Radial artery diameter was measured by high resolution ultrasound, forearm blood flow by strain gauge plethysmography, and pulse wave velocity by pressure recording cuffs placed over the distal brachial and radial arteries. Norepinephrine was used to constrict the radial artery to generate a greater range of vasodilator tone when examining pulse wave velocity. Despite dilating resistance vasculature, phentolamine and verapamil had little effect on radial artery diameter (mean dilation <9%). By contrast, for comparable actions on resistance vessels, nitroglycerine and nitroprusside but not brain natriuretic peptide had powerful actions to dilate the radial artery (dilations of 31.3±3.6%, 23.6±3.1%, and 9.8±2.0% for nitroglycerine, nitroprusside, and brain natriuretic peptide, respectively). Changes in pulse wave velocity followed those in arterial diameter irrespective of the signaling pathway used to modulate arterial tone (R=-0.89, P<0.05). Basal tone in human muscular arteries is relatively unaffected by α-adrenergic or calcium-channel blockade, but is functionally or directly antagonized by NO donors. The differential response to NO donors suggests that there is potential to manipulate the downstream pathway to confer greater specificity for large arteries with a resultant decrease in pressure wave reflection and systolic blood pressure.
机译:肌肉导管中的动脉张力可通过直径和脉搏波速度的变化影响压力波的反射。我们检查了臂内动脉灌注期间血管扩张药对radial动脉和前臂阻力血管的相对特异性。将一氧化氮(NO)供体,硝酸甘油和硝普钠以及脑利钠肽与α-肾上腺素拮抗剂酚妥拉明,钙通道拮抗剂维拉帕米和肼苯哒嗪进行比较。通过高分辨率超声测量动脉直径,通过应变仪体积描记法测量前臂血流,并通过放置在肱动脉和radial动脉远端的压力记录袖带测量脉搏波速度。在检查脉搏波速度时,使用去甲肾上腺素使the动脉收缩,以产生更大范围的血管扩张剂。尽管抗血管扩张,酚妥拉明和维拉帕米对radial动脉直径几乎没有影响(平均扩张<9%)。相比之下,对于在阻力血管上的可比作用,硝酸甘油和硝普钠而不是脑利钠肽具有强大的扩张the动脉的作用(硝化甘油,硝普钠和硝普钠的扩张度分别为31.3±3.6%,23.6±3.1%和9.8±2.0%脑利钠肽)。脉搏波速度的变化遵循动脉直径的变化,而与用于调节动脉张力的信号传导途径无关(R = -0.89,P <0.05)。人肌肉动脉的基础张力相对不受α-肾上腺素或钙通道阻滞的影响,但在功能上或直接受到NO供体的拮抗。对NO供体的不同反应表明,存在操纵下游通路以赋予大动脉更大特异性的潜力,从而导致压力波反射和收缩压降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号